Ratings & Reviews performance provides an overview of what users think of your app. Here are the key metrics to help you identify how your app is rated by users and how successful is your review management strategy.
Somryst Study is a digital therapeutic under investigation to treat chronic insomnia, which may have a benefit on both insomnia and co-occurring symptoms if present (such as depressive symptoms). Somryst Study is expected to deliver Cognitive Behavioral Therapy for Insomnia (CBT-I) over 9 weeks. CBT-I focuses on the behaviors, habits, routines, and thoughts that maintain sleep problems (regardless of the original cause of insomnia). CAUTION: Somryst Study is an investigational therapeutic device. It is limited by United States law to investigational use. Somryst Study is not yet available for sale in the United States.